Closing in on a cure


With the rollout of exon-skipping drugs that cost $300,000 a year and researchers focused on delivering corrections using compacted genes and CRISPR–Cas9, what is the future of treating this most common form of muscular dystrophy.

thumb nail

From Iowa to India


Pramod Mahajan, a Drake University pharmacy professor, used skills he learned in business to sell the school’s faculty on a program that sends Iowa students to learn about medicine and research in rural India.

thumb nail